Dounia CHRAA, Ph.D

Principle Research Scientist in Immuno-Oncology at Domain Therapeutics

Dounia CHRAA, Ph.D, currently serves as Ambassador Immunopeadia Europe at the International Union of Immunological Societies since January 2022 and as Principal Research Scientist in Immuno-Oncology at Domain Therapeutics since August 2022. Previous experience includes a postdoctoral researcher role at IGBMC from November 2020 to August 2022, part of Team Mei LI, and at Institut Paoli-Calmettes from December 2019 to October 2020 within Team Daniel OLIVE. Dounia CHRAA also completed a Ph.D. between December 2015 and November 2019 at Aix-Marseille University, contributing to research under the supervision of Daniel OLIVE at the Centre de Recherche en Cancérologie de Marseille. An internship was completed at IGBMC from May 2015 to August 2015.

Location

Illkirch-Graffenstaden, France

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Domain Therapeutics

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.


Headquarters

Illkirch, France

Employees

51-200

Links